Hyperuricemia
📧 Sign up to get email alerts when something new happens for Hyperuricemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-28FDA Approved: ALOPRIM — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for ALOPRIM (allopurinol) submitted by Mylan Institutional LLC. The action relates to updates in the…
-
EMA withdrawal · 2020-07-31EMA Withdrawn: Zurampic (lesinurad) — Grünenthal GmbH
Zurampic (lesinurad) has been withdrawn from EU marketing by Grünenthal GmbH after regulatory decision.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics [Phase 4]
Phase 4 trial investigating how BCRP Q141K affects allopurinol pharmacokinetics and pharmacodynamics in chronic gout and hyperuricemia. Comp…
-
FDA approval · 2020-06-02FDA Approved: FEBUXOSTAT — Original Application (HEC Pharm USA Inc.)
The FDA approved the original application for febuxostat submitted by HEC Pharm USA Inc., authorizing a generic version of febuxostat. Febux…
-
CLINICAL_TRIALS trial_result · 2020-05-21Clinical Trial Update: A Randomized Clinical Trail of The Effect of Postoperative Uric Acid Control on Stone Recurrence and Renal Function in Patients With Hyperuricemia of Urolithiasis. [Phase 4]
A Phase 4 randomized trial evaluating the effect of postoperative uric acid control on stone recurrence and renal function in patients with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction [Phase 4]
A Phase 4 clinical trial update on urate lowering therapies and their potential effects on left ventricular diastolic dysfunction in patient…
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms [Phase 3]
Phase 3 clinical trial evaluating the effects of allopurinol on inflammation and ultrasonographic changes in people with elevated uric acid …
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria [Phase 2]
Phase 2 trial evaluating intensive uric acid lowering with verinurad and febuxostat in patients with albuminuria completed; results posted i…
-
FDA approval · 2019-12-30FDA Approved: FEBUXOSTAT — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original Abbreviated New Drug Application for febuxostat (generic) by Novadoz Pharmaceuticals LLC.
-
FDA approval · 2019-12-30FDA Approved: FEBUXOSTAT — Original Application (Tris Pharma Inc)
The FDA approved an original application for febuxostat from Tris Pharma Inc, representing a generic product. The approval covers febuxostat…
-
FDA approval · 2019-12-12FDA Approved: ELITEK — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for ELITEK (rasburicase) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Traditional Chinese Medicine in the Treatment of Patients With Hyperuricemia. [Phase 2]
Phase 2 clinical trial evaluating traditional Chinese medicine for hyperuricemia has completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-02Clinical Trial Update: A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia [Phase 2]
A Phase 2 clinical trial evaluating safety and efficacy of SHR4640 in combination with febuxostat for hyperuricemia.
-
FDA approval · 2019-10-15FDA Approved: FEBUXOSTAT — Original Application (Hikma Pharmaceuticals USA Inc)
FDA approved Hikma Pharmaceuticals USA Inc for a generic febuxostat via an original ANDA (ANDA205414). This approval expands access to urate…
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia [Phase 2]
Phase II dose-finding study of RDEA3170 versus placebo in Japanese patients with gout or asymptomatic hyperuricemia completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia [Phase 2]
Phase 2 dose-finding and safety study of SHR4640 in hyperuricemia has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Zurig (Febuxostat) 40mg Efficacy and Safety Trial [Phase 4]
Phase 4 trial updating the efficacy and safety of Zurig (Febuxostat) 40 mg for hyperuricemia has been completed.
-
FDA approval · 2019-07-01FDA Approved: FEBUXOSTAT — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' original application for febuxostat (generic febuxostat). This ANDA approval provides a generic …
-
FDA approval · 2019-07-01FDA Approved: FEBUXOSTAT — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original ANDA for febuxostat, a generic version of the gout and hyperuricemia therapy.
-
FDA label_change · 2019-04-23FDA Approved: ALLOPURINOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for allopurinol submitted by Zydus Lifesciences Limited, indicating changes to the product labeling.
-
FDA approval · 2019-04-23FDA Approved: ALLOPURINOL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Allopurinol from Mylan Pharmaceuticals Inc., representing a supplemental approval for the produc…
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women. [Phase 4]
Phase 4 trial evaluating whether estrogen-progestin therapy reverses an unfavorable effect of hydrochlorothiazide on serum uric acid and oxy…
-
FDA approval · 2019-03-19FDA Approved: ALLOPURINOL — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for allopurinol (generic) submitted by Chartwell RX, LLC.
-
FDA approval · 2019-03-12FDA Approved: ALLOPURINOL — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved Unichem Pharmaceuticals (USA), Inc.'s original application for Allopurinol, a generic drug used to treat gout and hyperuric…
-
CLINICAL_TRIALS research · 2019-02-22Clinical Trial Update: Associations Between Tea and Sweetened Beverage Consumptions and Hyperuricemia: The China Health and Nutrition Survey
This clinical trial update investigates associations between tea and sweetened beverage consumption and hyperuricemia using data from the Ch…